聚焦证据:视网膜母细胞瘤治疗随机试验的稀缺景观

Georgios Lavasidis1,2, Kyriaki Papaioannou3, Nikolaos Anagnostou1

  • 1Evidence-based Medicine Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

概括

温克里斯,埃托波西德和卡博普拉丁 (VEC) 化疗对视网膜母细胞瘤有希望. 然而,需要进一步的随机试验来确认这种罕见的眼睛癌症的疗效和优化治疗.